NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
31 March 2025
| Name: | EBR SYSTEMS INC. (EBR) |
| ISIN: | AU0000182552 |
| Date of Listing: | 24 November 2021 |
Stock Exchange Status: (updated daily)
This entity is currently listed and quoted on the Australian Securities Exchange.Legal Status: (updated monthly)
This is a current registered entity, not in any form of external administration to our knowledge.Capital Gains Tax (CGT) Status: (updated at least quarterly)
To crystallise a capital gain or capital loss on your securities in this entity, you are able to sell your securities on-market in the normal manner. If you determine that the market in your securities is illiquid and you still wish to crystallise a capital gain or loss, kindly contact deListed at admin@delisted.com.au for suggestions as to how you might proceed.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
Computershare Melbourne
Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail
Expand this box to read and print
The suspension of trading in the securities of EBR Systems Inc. will be lifted immediately following the release by EBR of an update in relation to its WiSE Device. | 21/10/2022 |
The company releases a Shareholder and Investor Webinar Presentation. | 21/10/2022 |
EBR has identified a potential increased rate of battery depletion caused by the transmitter in some WiSE systems. Affected devices have not impacted patient health or safety to date and EBR is working closely with relevant clinical sites and regulatory bodies to provide patient management recommendations. EBR does not expect this development to materially impact the timing or data of headline results for the pivotal SOLVE trial, which remain on track for release in H1 2023. The Company has engaged with the relevant regulatory bodies and expects resolution of this matter prior to final PMA submission to the FDA in H2 2023. EBR does not expect the issue to have a material impact on funding requirements, with the Company's strong cash position (US$79.3m as of 30 June 2022) sufficient to support the pathway to FDA approval and commercialisation. | 21/10/2022 |
The company invites shareholders and investors to a live webinar scheduled on: Friday, 21 October 2022 at 9.15am "“ 9.45am AEDT. The webinar will last for 30 minutes. | 20/10/2022 |
The securities of EBR Systems, Inc. will be suspended from quotation immediately under Listing Rule 17.2, at the request of EBR, pending the release of an announcement regarding a potential manufacturing change to EBR's product. | 14/10/2022 |
listed entity carried for record purposes only | 24/11/2021 |
The suspension of trading in the securities of EBR Systems Inc. will be lifted immediately following the release by EBR of an update in relation to its WiSE Device. | 21/10/2022 |
The company releases a Shareholder and Investor Webinar Presentation. | 21/10/2022 |
EBR has identified a potential increased rate of battery depletion caused by the transmitter in some WiSE systems. Affected devices have not impacted patient health or safety to date and EBR is working closely with relevant clinical sites and regulatory bodies to provide patient management recommendations. EBR does not expect this development to materially impact the timing or data of headline results for the pivotal SOLVE trial, which remain on track for release in H1 2023. The Company has engaged with the relevant regulatory bodies and expects resolution of this matter prior to final PMA submission to the FDA in H2 2023. EBR does not expect the issue to have a material impact on funding requirements, with the Company's strong cash position (US$79.3m as of 30 June 2022) sufficient to support the pathway to FDA approval and commercialisation. | 21/10/2022 |
The company invites shareholders and investors to a live webinar scheduled on: Friday, 21 October 2022 at 9.15am "“ 9.45am AEDT. The webinar will last for 30 minutes. | 20/10/2022 |
The securities of EBR Systems, Inc. will be suspended from quotation immediately under Listing Rule 17.2, at the request of EBR, pending the release of an announcement regarding a potential manufacturing change to EBR's product. | 14/10/2022 |
listed entity carried for record purposes only | 24/11/2021 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 15/03/2024 | Bronwyn Evans | 17,413 | $0.715 | $12,450 |
| 06/03/2024 | Bronwyn Evans | 22,033 | $0.810 | $17,847 |
| 27/11/2023 | Bronwyn Evans | 5,000 | $0.609 | $3,043 |
| 22/11/2023 | Bronwyn Evans | 20,000 | $0.648 | $12,961 |
| 06/03/2023 | Bronwyn Evans | 8,963 | $0.670 | $6,005 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Allan Will | Executive Chairman | 24/11/2021 |
| John McCutcheon | President, Director | 24/11/2021 |
| Michael Hendrickson | COO | 29/11/2021 |
| Gary Doherty | CFO | 11/09/2023 |
| Bronwyn Evans | Non Exec Director | 24/11/2021 |
| Trevor Moody | Non Exec Director | 24/11/2021 |
| Chris Nave | Non Exec Director | 24/11/2021 |
| Karen Drexler | Non Exec Director | 24/11/2021 |
| David Steinhaus | Non Exec Director | 24/11/2021 |
| Brendan Case | Company Secretary | |
| John H Sellers | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Frank Hettmann | CFO | 24/11/2021 | 11/09/2023 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.
